Jay Venkatesan - 20 Dec 2021 Form 4 Insider Report for Angion Biomedica Corp. (ELTX)

Role: President and Chief Executive Officer and Director, Director
Signature: /s/ Jennifer J. Rhodes, as attorney-in fact for Jay. R. Venkatesan
Issuer symbol: ELTX
Transactions as of: 20 Dec 2021
Net transactions value: +$8,976
Form type: 4
Filing time: 22 Dec 2021, 15:06:45 UTC
Previous filing: 20 Dec 2021
Next filing: 29 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELTX	Common Stock	Purchase	$8,976	+3,527	+0.26%	$2.54	1,362,013	20 Dec 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.52 to $2.55 inclusive.

Remarks:

President and Chief Executive Officer and Director